It’s been called the first “Viagra for women” and hailed as a health breakthrough. But Addyi (generic name flibanserin) is sparking ire just as it claims to spark desire. Is this drug a boon for feminism because it finally gives women what men have enjoyed since 1998: prescription medication that can effectively boost sagging libidos? Or are the drug’s pluses (an average increase of 0.5 to 1 “sexually satisfying events per month”) not really worth its potential side effects of nausea, dizziness and fainting? Читать дальше...
Public interest in progressive financial reform is growing. After the epic crash of 2008 and the “Great Recession,” and with a boost from a sharply populist campaign season, a number of left-of-center proposals have circulated around the question of what to do about the banking system, which has molded contemporary society in its image and defines the horizon of what is politically possible.
Читать дальше...